MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Immunovant, Inc. Common Stock

IMVT

#1145
Immunovant, Inc. Common Stock
27.7300
+3.28%
Sector:
Base:
Profit Currency:
Daily Range
27.7300
27.7300
Year Range
19.2100
29.2500
Daily Change
+3.28%
Monthly Change
+3.47%
6 month change
+44.35%
Year Change
+44.35%
Previous Close
26.8500
Open
27.7300
Bid
Ask
Low
27.7300
High
27.7300
Volume
113
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. IMVT
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
IMVT
2026.02.25
Immunovant stock hits 52-week high at 28.32 USD
Zacks Zacks
AXSM CSTL IMVT INDV
2026.02.19
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Zacks Zacks
AXSM CSTL IMVT ARQT
2026.02.17
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Zacks Zacks
AXSM CSTL IMVT RXRX
2026.02.17
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Zacks Zacks
ALKS EXEL CSTL IMVT
2026.02.09
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Investing Investing
IMVT
2026.02.09
Immunovant stock hits all-time high at 27.87 USD
Seeking Alpha Seeking Alpha
IMVT
2026.02.06
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Investing Investing
IMVT
2026.02.06
Immunovant shares jump 7% as Q3 loss narrows, beats estimates
Investing Investing
BIIB AN PIPR PM NWL
2026.02.05
Philip Morris, Biogen, Telenor, and more set to report earnings Friday
Investing Investing
IMVT
2026.02.05
Immunovant earnings up next as Graves’ disease optimism builds
Zacks Zacks
IMVT
2026.02.02
Wall Street Analysts Predict a 55.04% Upside in Immunovant (IMVT): Here's What You Should Know
Zacks Zacks
IMVT
2026.01.15
How Much Upside is Left in Immunovant (IMVT)? Wall Street Analysts Think 47.39%

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd